Cecelia Health

Overview
Activities
News
Preventive Healthcare?
Product stageSegments
Growth
?
Chronic Care Management
?

Cecelia Health is a virtual specialty clinic for patients with chronic illnesses and diabetes. The company has designed and created a solution to improve the healthcare user experience (healthcareUX). Cecelia Health looks to increase access to care and offer life-changing support from dedicated clinical specialists via its virtual specialty clinic, remote patient monitoring, education, and device training, backed by first-party data and sophisticated analytics. 

The company addresses a variety of chronic illnesses and spans therapeutic domains including cardiovascular disease, chronic renal disease, diabetes, and respiratory problems. 

Key customers and partnerships

In April 2022, the company collaborated with UBMD Paediatrics to improve outcomes for children and adolescents with Type 1 diabetes. Also, in April 2022, Cecelia Health collaborated with Joslin Diabetes Centre to increase the use of continuous glucose monitors (CGMs) among older adults with diabetes. 

In August 2021, LifeScan and Cecelia Health collaborated to provide a new live Certified Diabetes Care and Education Specialists (CDCES) telehealth service via the OneTouch Reveal app. In January 2019, Cecelia Health partnered with Valeritas on the V-Go wearable insulin delivery device for diabetics. Also, in December 2021, Cecelia Health looked to strengthen its position in the life sciences market by partnering with a leading diabetes brand to provide virtual patient support.

Funding and Financials

In August 2020, Cecelia Health raised USD 13 million in a series B round led by Rittenhouse Ventures and Endo Investors. The funds were expected to be used to accelerate and scale up the adoption of Cecelia Health's technology-enabled coaching and telemedicine solutions while also expanding its digital health capabilities.

HQ location:
355 Lexington Avenue New York NY USA
Founded year:
2009
Employees:
51-100
IPO status:
Private
Total funding:
USD 22.4 mn
Last Funding:
USD 13.0 mn (Series B; Aug 2020)
Last valuation:
-
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.